Skip to main content
. 2021 Jul 13;109:106501. doi: 10.1016/j.cct.2021.106501

Table 1.

Study outcomes and definitions.

Study outcome Analysis denominator Outcome definition
Recognition of CKD Study eligible and no documentation of CKD at index CKD diagnosis code (ICD10) assigned at an inpatient or outpatient encounter, or the entry of CKD diagnosis on the problem list, from index through 18 months post-index
BP control Study eligible and BP care gap identified at indexa Most recent systolic BP (SBP) and diastolic BP (DBP) values in the 18 months post-index in the recommended range using office BP measurements
ACEI or ARB use Study eligible and ACEI / ARB use care gap identified at indexa Prescription for an ACEI or ARB medication in the 18 months post-index
Glucose control Study eligible and glucose care gap identified at indexa Last A1C value in the 18 months post-index below the A1C goal recommendation
Nephrology referral Study eligible and nephrology visit care gap at indexa Referral to nephrology (electronic) in the 18 months post-index period.
a

Care gaps for the analysis denominators are the same as those defined in the inclusion criteria.